The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I

被引:20
作者
Hulme, C
Moriarty, K
Miller, B
Mathew, R
Ramanjulu, M
Cox, P
Souness, J
Page, KM
Uhl, J
Travis, J
Huang, FC
Labaudiniere, R
Djuric, SW
机构
[1] Rhone Poulenc Rorer Cent Res, Collegeville, PA 19426 USA
[2] Rhone Poulenc Rorer Cent Res, Dagenham, Essex, England
关键词
D O I
10.1016/S0960-894X(98)00324-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This communication describes the synthesis and in vitro evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. The compounds described contain an indole moiety which replaces the 'rolipram-like' 3-methoxy-4-cyclopentoxy motif. Several of the compounds presented possess low nanomolar IC50's for PDEIV inhibition. In vivo activities determined from measurement of serum TNF-alpha levels in LPS challenged mice (mouse endotoxemia model) are also reported. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1867 / 1872
页数:6
相关论文
共 25 条
[1]   SELECTIVE TYPE-IV PHOSPHODIESTERASE INHIBITORS AS ANTIASTHMATIC AGENTS - THE SYNTHESES AND BIOLOGICAL-ACTIVITIES OF 3-(CYCLOPENTYLOXY)-4-METHOXYBENZAMIDES AND ANALOGS [J].
ASHTON, MJ ;
COOK, DC ;
FENTON, G ;
KARLSSON, JA ;
PALFREYMAN, MN ;
RAEBURN, D ;
RATCLIFFE, AJ ;
SOUNESS, JE ;
THURAIRATNAM, S ;
VICKER, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (11) :1696-1703
[2]  
BEAVO JA, 1994, MOL PHARMACOL, V46, P399
[3]   1,4-cyclohexanecarboxylates: Potent and selective inhibitors of phosphodiesterase 4 for the treatment of asthma [J].
Christensen, SB ;
Guider, A ;
Forster, CJ ;
Gleason, JG ;
Bender, PE ;
Karpinski, JM ;
DeWolf, WE ;
Barnette, MS ;
Underwood, DC ;
Griswold, DE ;
Cieslinski, LB ;
Burman, M ;
Bochnowicz, S ;
Osborn, RR ;
Manning, CD ;
Grous, M ;
Hillegas, LM ;
Bartus, JO ;
Ryan, MD ;
Eggleston, DS ;
Haltiwanger, RC ;
Torphy, TJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (06) :821-835
[4]   Quaternary substituted PDE4 inhibitors I: The synthesis and in vitro evaluation of a novel series of oxindoles [J].
Hulme, C ;
Poli, GB ;
Huang, FC ;
Souness, JE ;
Djuric, SW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (02) :175-178
[5]   Quaternary substituted PDE IV inhibitors II:: The synthesis and in vitro evaluation of a novel series of γ-lactams [J].
Hulme, C ;
Moriarty, K ;
Huang, FC ;
Mason, J ;
McGarry, D ;
Labaudiniere, R ;
Souness, J ;
Djuric, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (04) :399-404
[6]   Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNFα inhibitory activity of two series of rolipram analogues:: Implications for a new active site model of PDE4 [J].
Kleinman, EF ;
Campbell, E ;
Giordano, LA ;
Cohan, VL ;
Jenkinson, TH ;
Cheng, JB ;
Shirley, JT ;
Pettipher, ER ;
Salter, ED ;
Hibbs, TA ;
DiCapua, FM ;
Bordner, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :266-270
[7]   NEW COUPLING REAGENTS IN PEPTIDE CHEMISTRY [J].
KNORR, R ;
TRZECIAK, A ;
BANNWARTH, W ;
GILLESSEN, D .
TETRAHEDRON LETTERS, 1989, 30 (15) :1927-1930
[8]   INHIBITION OF CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE FROM VASCULAR SMOOTH-MUSCLE BY ROLIPRAM ANALOGS [J].
MARIVET, MC ;
BOURGUIGNON, JJ ;
LUGNIER, C ;
MANN, A ;
STOCLET, JC ;
WERMUTH, CG .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (07) :1450-1457
[9]   DISCOVERY OF MICROMOLAR PDE-IV INHIBITORS THAT EXHIBIT MUCH REDUCED AFFINITY FOR THE [H-3]ROLIPRAM BINDING-SITE - 3-NORSORNYLOXY-4-METHOXYPHENYLMETHYLENE OXINDOLES [J].
MASAMUNE, H ;
CHENG, JB ;
COOPER, K ;
EGGLER, JF ;
MARFAT, A ;
MARSHALL, SC ;
SHIRLEY, JT ;
TICKNER, JE ;
UMLAND, JP ;
VAZQUEZ, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (17) :1965-1968
[10]  
MATSUURA A, 1994, BIOL PHARM BULL, V177, P498